Hologic Inc. (NASDAQ:HOLX) finished Wednesday with a subtraction of -$1.76 to close at $62.89, a downside of -2.72 percent. An average of 1,902,440 shares of common stock have been traded in the last five days. There was a fall of -$5.10 in the past week, and it reached a new high 6 times over the past 12 months. The last 20 days have seen an average of 1,505,630 shares traded, while the 50-day average volume stands at 1,541,162.
HOLX stock has decreased by -10.07% in the last month. The company shares reached their 1-month lowest point of $62.73 on 09/21/22. With the stock rallying to its 52-week high on 04/08/22, shares of the company touched a low of $64.03 and a high of $80.49 in 52 weeks. It has reached a new high 6 times so far this year and lost -17.86% or -$13.67 in price. In spite of this, the price is down -21.87% from the 52-week high.
Top 5 Cheap Stocks to Own Right Now
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now. .
128 days have passed since Hologic Inc. (HOLX) last reported insider trading activity. Verstreken Jan, who is Group President, International, most recently acquired $6,500 shares at $78.80 per share on May 17. In this transaction, the insider spent $512,168. Principal Accounting Officer, COHN BENJAMIN JORDAN, disposed of 3,844 shares at a price of $78.75 on May 17. The insider now owns more than $302,730 worth of shares. Prior to that, Principal Accounting Officer COHN BENJAMIN JORDAN went on to Sale 7,052 shares at $75.49 each on May 13. An amount of $532,365 was transacted.
Hologic Inc. (HOLX) has a trailing price-to-earnings (P/E) ratio of 10.59. The stock’s beta is 1.05. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 3.04, the price-to-book (PB) ratio at 3.16, and the price-to-cash flow ratio at 6.73.
The quick ratio of Hologic Inc. for the three months ended June 29 was 3.30, and the current ratio was 3.90, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.57 and a total debt to equity ratio of 0.57 for the quarter ending June 29. Hologic Inc.’s EBITDA margin for the year ending June 29 is 51.31%, while its operating margin for the same period stands at 37.10%. Its gross profit as reported stood at $3.8 billion compared to revenue of $5.63 billion.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Hologic Inc.’s return on assets was 16.30%.
For the three-month period that ended June 29, Hologic Inc. had $2.81 billion in total debt. In the quarter under review, the net income was down than the previous quarter. The company posted a net income of $228.4 million in the quarter, while revenues of $455.7 million were shrunk -17.38%. The analyst consensus anticipated Hologic Inc.’s latest quarter earnings to come in at $0.71 per share, but it turned out to be $0.95, a 33.80% surprise. For the quarter, EBITDA amounted to $373.3 million. Shareholders own equity worth $249.65 million.
From a technical analysis perspective, let’s take a brief look at Hologic Inc. (HOLX) price momentum. RSI 9-day as of the close on 21 September was 19.52%, suggesting the stock is oversold, with historical volatility in this time frame at 21.01%.
As of today, HOLX’s price is $65.73 -7.50% or -$5.10 from its 5-day moving average. HOLX is currently trading -9.43% lower than its 20-day SMA and -11.92% lower than its 100-day SMA. However, the stock’s current price level is -11.02% below the SMA50 and -14.94% below the SMA200.
The stochastic %K and %D were 10.83% and 14.57%, respectively, and the average true range (ATR) was 1.64. With the 14-day stochastic at 2.07% and the average true range at 1.58, the RSI (14) stands at 26.59%. The stock has reached -2.36 on the 9-day MACD Oscillator while the 14-day reading was at -2.69.
UBS launched coverage on Hologic Inc. (NASDAQ: HOLX) in its analyst report released on July 20, 2022. The firm assigned the stock a Neutral rating. The consensus rating for Hologic Inc. (HOLX) among analysts is Overweight. According to current brokerage recommendations, 0 brokerage firms advise that investors sell HOLX, while 10 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 2 analysts, while 6 others rate it as a “buy”.
What is HOLX’s price target for the next 12 months?
Analysts predict a range of price targets between $64.00 and $90.00, with a median target of $78.50. Taking a look at these predictions, the average price target given by analysts for Hologic Inc. (HOLX) stock is $79.10.